Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC EHT 5372 | 1425945-63-6 | 98.12% | 404.27 | 25 MG
SDP

Catalog No. 5000346819
Encompass_Preferred

EHT 5372 is a potent and selective inhibitor of DYRK's family kinases, demonstrating high inhibitory activity against DYRK1A and DYRK1B. It also shows inhibitory effects on DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, and GSK-3β. This compound has applications in various research areas, including neurological disorders like Alzheimer's Disease, cancer, and diabetes, by reducing pS396-Tau levels and Aβ production.

  • Potent and selective inhibitor of DYRK's family kinases
  • Inhibits DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, and GSK-3β
  • Reduces pS396-Tau levels
  • Reduces Aβ production
  • Suitable for research in neurological disorders, cancer, and diabetes

Catalog No. 50-003-46819 Supplier Medchemexpress LLC Supplier No. 25MGHY111379
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EHT 5372 is a potent and selective inhibitor of DYRK's family kinases, demonstrating high inhibitory activity against DYRK1A and DYRK1B. It also shows inhibitory effects on DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, and GSK-3β. This compound has applications in various research areas, including neurological disorders like Alzheimer's Disease, cancer, and diabetes, by reducing pS396-Tau levels and Aβ production.

  • Potent and selective inhibitor of DYRK's family kinases
  • Inhibits DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, and GSK-3β
  • Reduces pS396-Tau levels
  • Reduces Aβ production
  • Suitable for research in neurological disorders, cancer, and diabetes

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.